Ulrich Thienel

Ulrich was formerly Chief Medical Officer at Finch Therapeutics, Boston. Prior to Finch, Ulrich had 20 years of biopharmaceutical drug development leadership, with experience in both biotech and large pharma, including Johnson & Johnson, BMS, and Takeda. His experience spans autoimmune, hematology, respiratory and rare diseases. In previous roles as Therapeutic Area Leader and Chief of Development and Medical Officer, he oversaw research development and commercialization of multiple assets, including small molecules, siRNA, antibody and device technologies. He is well versed in FDA regulatory processes, including experience with multiple Investigational New Drugs (INDs), New Drug Applications (NDAs) and Biologics License Applications (BLAs).